RS-25344

CAS No. 152814-89-6

RS-25344( —— )

Catalog No. M23659 CAS No. 152814-89-6

RS-25344 is a potent and selective phosphodiesterase (PDE) 4 inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 187 In Stock
5MG 172 In Stock
10MG 258 In Stock
25MG 426 In Stock
50MG 586 In Stock
100MG 792 In Stock
200MG 1051 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    RS-25344
  • Note
    Research use only, not for human use.
  • Brief Description
    RS-25344 is a potent and selective phosphodiesterase (PDE) 4 inhibitor.
  • Description
    RS-25344 is a potent and selective phosphodiesterase (PDE) 4 inhibitor. It inhibits eosinophil chemotaxis and increases progressive motility of spermatozoa in vitro.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    PDE
  • Recptor
    PDE4| PDE1|PDE2|PDE3
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    152814-89-6
  • Formula Weight
    375.34
  • Molecular Formula
    C19H13N5O4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    [O-][N+](c1cc(N(c2ncccc2C(N2Cc3ccncc3)=O)C2=O)ccc1)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Bajpai et al (2006) AKAP3 selectively binds PDE4A isoforms in bovine spermatozoa. Biol.Reprod. 74 109.
molnova catalog
related products
  • Apremilast

    Apremilast (CC-10004) is a potent, orally active PDE4 inhibitor with IC50 of 74 nM, inhibits TNF-α production in LPS-stimulated hPBMCs with IC50 of 77 nM.

  • Difamilast

    Difamilast (OPA-15406) is a novel potent, selective phosphodiesterase IV (PDE4) inhibitor with preference for PDE4B (IC50=11.2 nM).?

  • Propentofylline

    Propentofylline (Hextol) is a methylxanthine derivative with neuroprotective, antiproliferative, and anti-inflammatory activity and enhanced synaptic adenosine signaling, which may be useful in the study of Alzheimer's disease, vascular dementia, cognitive impairment, dementia, and chronic pain.